Daisuke Aoki

62PUBLICATIONS
288CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Geriatrics and gerontologyReproductionMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (62)

|Aug 07, 2026
cfDNA-inferred putative clonal hematopoiesis during first-line platinum-to-PARP inhibitor maintenance in ovarian cancer.

|Jul 25, 2026
A confirmatory trial of hysterectomy with minimal parametrectomy for stage IB1 cervical cancer involving a tumor diameter of 2 cm or less: a Japan Clinical Oncology Group study (JCOG1101).

|Jun 19, 2026
Nationwide survey of hereditary breast and ovarian cancer-related clinical practice in gynecologic oncology in Japan: a joint study by the Japan Society of Gynecologic Oncology (JSGO) and the Japan Society of Obstetrics and Gynecology (JSOG).

|Nov 10, 2025
Prognostic Biomarker of Fertility-Preserving Hormonal Therapy Based on Multigene Panel Testing for Endometrial Cancer.

Takuro Hirano, Kensuke Sakai, Takuma Yoshimura

|Jun 03, 2025
Hormone replacement therapy in female-specific cancer survivors: considerations beyond cancer cure.

Tomoko Yoshihama, Megumi Yokota, Daisuke Aoki

|Jun 03, 2025
High-Throughput Drug Screening of Clear Cell Ovarian Cancer Organoids Reveals Vulnerability to Proteasome Inhibitors and Dinaciclib and Identifies AGR2 as a Therapeutic Target.

Takuma Yoshimura, Takashi Kamatani, Aki Ookubo

Pageof 11

Frequent Collaborators

20 joint publications

Yusuke Kobayashi

15 joint publications

Wataru Yamagami

11 joint publications

Kouji Banno

10 joint publications

Mikio Mikami